Submissions

Author Guidelines

The authors should submit papers for the journal Current Issues in Pharmacy and Medical Sciences via the internet platform:https://www.editorialsystem.com/cipms/ )

All submissions are initially evaluated by an editor to determine whether they fit the aims and scope of the journal. Manuscripts considered suitable are sent for peer review before a final decision on acceptance or rejection.

Before submission, authors are responsible for obtaining permission to publish any material included in the manuscript, such as images, documents, or datasets. All listed authors must consent to be identified as co-authors. Research involving humans or animals must be approved by an appropriate ethics committee in accordance with the legal requirements of the country where the study was conducted.

An editor may desk reject a submission if it does not meet minimum quality standards. Before submitting, ensure that:

  • The study design and research argument are well-structured and clearly presented.
  • The title is concise and informative.
  • The abstract is self-contained and accurately reflects the content of the manuscript.

Following these recommendations increases the likelihood that reviewers will agree to evaluate the manuscript.

Ethical Standards

  • Articles must be original and not submitted elsewhere.
  • Authors must disclose any conflicts of interest.
  • Research involving humans or animals must have ethics committee approval.

Manuscript Structure

All manuscripts should be written in English and include the following sections:

  1. Title – concise and descriptive.
  2. Abstract – up to 250 words; summarize the aim, methodology, key results, and conclusions.
  3. Keywords – 3–6 words, preferably aligned with MeSH terms.
  4. Introduction – background, rationale, and objectives of the study.
  5. Materials and Methods – detailed description of experimental design, materials, and analytical procedures.
  6. Results – presentation of findings in text, tables, and figures.
  7. Discussion – interpretation of results, comparison with existing literature, study limitations, and future perspectives.
  8. Conclusions – brief summary of main findings.
  9. Acknowledgements – optional; credit to individuals or institutions that contributed.
  10. References – follow the journal’s citation style (APA recommended).

Tables and Figures

  • Number all tables and figures consecutively and provide descriptive titles.
  • Each table or figure should be understandable without referring to the text.
  • Explain all abbreviations, symbols, and units in legends.
  • Submit figures and tables in editable or high-resolution formats (e.g., Excel, Word, TIFF, JPEG).

Citations

  • References in the text should follow APA style.
  • All cited sources must appear in the reference list.
  • Prefer recent references (last 5 years) for fast-evolving topics.

ORCID

Authors submitting their manuscripts to Current Issues in Pharmacy and Medical Sciences are requested to enter their unique ORCID (Open Researcher and Contributor ID) number. ORCID is a unique digital identifier that makes it possible to distinguish between authors with the same surname and to correctly assign publications to individuals in scientific databases. You can obtain your ORCID number free of charge at: https://orcid.org.

Use of AI Tools

AI-based tools (e.g., ChatGPT, Copilot) may be used to support the writing process, but cannot replace the author’s personal input. Authors remain fully responsible for the accuracy, content, and references of the manuscript, as well as for any potential copyright issues.

  • Transparency: If AI tools were used at any stage, authors must clearly disclose their usage, including tools and prompts employed.
  • Permitted Use: AI may assist with text correction, content suggestions, or bibliography management.
  • Disclosure Requirement: Simple spelling or grammar corrections do not require disclosure; extensive use (e.g., content generation) must be disclosed.
  • Editorial Review: Each case of AI use is evaluated individually by the editorial board.

Payment

Publication requires a publication fee.

Once the manuscript is accepted, the author should pay 600 PLN (or 135 EUR) to the following bank account:

In PLN:

  • Account number: 94 1020 3147 0000 8302 0084 6188
  • Bank: PKO BP Oddział 1 w Lublinie
  • SWIFT: BPKOPLPW

In EUR:

  • Account number: PL50 1020 3147 0000 8202 0084 6253
  • Bank: PKO BP S.A. O/Lublin
    ul. Watykańska 7
    20-538 Lublin

Payment Note: CIPMS, Surname and Name of the first author, ID of the submitted article.

Submission Preparation Checklist

All submissions must meet the following requirements:

  • Manuscript complies with the Author Guidelines.
  • Work is original, not previously published or submitted elsewhere.
  • All references are accurate and complete.
  • All tables and figures are numbered and labeled.
  • Permission obtained for all images, datasets, and supplementary material.

Privacy Statement

Data protection information for authors

The Medical University of Lublin, located at Al. Raclawickie 1, 20-059 Lublin, NIP 712-010-69-11, REGON 000288710 (hereinafter: UM), as the controller of personal data, informs that the data collected in the Publishing House of the Medical University of Lublin will be processed only for the purpose of correct implementation of the publishing contract. The area of data processing in the authors' collection is the editorial offices of the journals and the Publishing House of the Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, hereinafter referred to as the Publishing House.

The data will be processed by the ADO on the basis of Article 6(1)(b) of the Regulation (EU)2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data and repealing Directive 95/46/EC (the so-called. General Data Protection Regulation/RODO), i.e. in connection with the fact of entering into a contract, in particular for archival purposes and the establishment and assertion of possible claims, during the period of fulfillment of the purpose of processing, and thereafter for the periods allowed by law or provided for by ADO's internal norms.

In accordance with Articles 15-21 and Article 77 of the General Data Protection Regulation, the data subject has the right to access, rectify, erase or restrict data processing, the right to object to data processing and to lodge a complaint with a supervisory authority, as well as the right to data portability.

Provision of data is voluntary, but necessary for the purpose of data processing, i.e. for the proper execution of the publishing contract. ADO also informs that no decisions will be made on the basis of personal data in an automated manner, they will not be subject to sale or sharing with external entities, except for the subjects and circumstances of their disclosure provided by law.

ADO designates a person responsible for ensuring compliance with the law on personal data protection, who can be contacted at e-mail: iod@umlub.pl.